Baxter International (BAX) is poised for growth, given the demand for its medically essential products, coupled with transformational actions. However, inflationary pressure remains a concern.Shares of this Zacks Rank #3 (Hold) company have lost 12.4% year to date against the industry's 3.1% growth. The S&P 500 Index has increased 11.6% in the same time frame.BAX, with a market capitalization of $17.27 billion, is a global medical technology company providing items such as kidney-dialysis equipment, infusio ...